1 / 6

Helicobacter pylori

Helicobacter pylori. Ricardo A. Caicedo, M.D . Pediatric Gastroenterology. 2005 Nobel Prize for Medicine. J.R. Warren & B. Marshall. Infects > 50% humans Most are asymptomatic 10-15% will develop PUD Almost always acquired in childhood Risk factors Infected family member

tuan
Télécharger la présentation

Helicobacter pylori

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Helicobacter pylori Ricardo A. Caicedo, M.D. Pediatric Gastroenterology

  2. 2005 Nobel Prize for Medicine J.R. Warren & B. Marshall

  3. Infects > 50% humans Most are asymptomatic 10-15% will develop PUD Almost always acquired in childhood Risk factors Infected family member Crowded living conditions Lower socioeconomic status Daycare Immigrant/international adoptee Transmission Fecal-oral Oral-oral Within famililes The Dreaded Helicobacter CzinnS (2005) J. Pediatr 146: S21-26

  4. Why care about H. pylori infection? • - Peptic ulcer disease • Atrophic gastritis: precursor to gastric • adenocarcinoma or MALT lymphoma • - Iron deficiency anemia • - Growth retardation (possible association)

  5. Diagnosis • Indications for testing • DU or GU • Endoscopically dx’d • Radiographically definitive • MALT lymphoma • Follow-up of documented H. pylori disease • Not recommended • Asymptomatic children • Recurrent abdominal pain without documented PUD • Family hx of gastric cancer or recurrent PUD Gold Std Gold BD et al.(2000) NASPGHAN GuidelinesJPGN 31: 490-97.

  6. Treatment • Indications • DU/GU with Hp on bx • Prior hx DU/GU with active Hp • Atrophic gastritis w/intestinal metaplasia + Hp • Judgement call: • Hp+ gastritis w/o PUD • Not recommended • Asymptomatic child + family member w/Hp, PUD, or gastric cancer • Hp+ child with nonulcer dyspepsia or functional abdominal pain CzinnS (2005) J. Pediatr 146: S21-26

More Related